Anti-murine CXCR5 CAR-T cells exhibit potent anti-tumor activity in vitro, and most importantly, facilitate specific benign and malignant B and CXCR5+ Tfh cell depletion without further off-target activity in a syngeneic mouse model. This evidence concerns the gene CXCR5 and neoplasm.